Featured Research

from universities, journals, and other organizations

A better way of estimating blood loss

Date:
March 6, 2013
Source:
BioMed Central Limited
Summary:
Research suggests that there may be a better way of measuring blood loss due to trauma than the current method, finds a new article. The study shows that base deficit (BD) is a better indicator of hypovolemic shock than the Advanced Trauma Life Support (ATLS) classification, which uses a combination of heart rate, systolic blood pressure and the Glasgow Coma Scale.

Research suggests that there may be a better way of measuring blood loss due to trauma than the current method, finds an article in BioMed Central's open access journal Critical Care. The study shows that base deficit (BD) is a better indicator of hypovolemic shock than the Advanced Trauma Life Support (ATLS) classification, which uses a combination of heart rate, systolic blood pressure and the Glasgow Coma Scale.

Using data from the TraumaRegister DGU® 16,305 patients injured between 2002 and 2010 were classified according to BD and then assessed for demographics, injury characteristics, and transfusion and fluid requirements. Severity of injury, length of stay in ICU or in hospital, morbidity and mortality were all linked to BD. Increase in BD category was associated with worse hypotension, needing more blood, intubation and mechanical breathing.

When validated to the current ATLS classification BD was more accurate at predicting the patients who needed blood products, and the need for massive transfusions. BD was also better at predicting who was at highest risk of death.


Story Source:

The above story is based on materials provided by BioMed Central Limited. Note: Materials may be edited for content and length.


Journal Reference:

  1. Manuel Mutschler, Ulrike Nienaber, Thomas Brockamp, Arasch Wafaisade, Tobias Fabian, Thomas Paffrath, Bertil Bouillon, Marc Maegele, TraumaRegister Dgu. Renaissance of base deficit for the initial assessment of trauma patients: a base deficit-based classification for hypovolemic shock developed on data from 16,305 patients derived from the TraumaRegister DGU. Critical Care, 2013; 17 (2): R42 DOI: 10.1186/cc12555

Cite This Page:

BioMed Central Limited. "A better way of estimating blood loss." ScienceDaily. ScienceDaily, 6 March 2013. <www.sciencedaily.com/releases/2013/03/130305200314.htm>.
BioMed Central Limited. (2013, March 6). A better way of estimating blood loss. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2013/03/130305200314.htm
BioMed Central Limited. "A better way of estimating blood loss." ScienceDaily. www.sciencedaily.com/releases/2013/03/130305200314.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins